XBP1 and obesity disorder: In conclusion, our study presents a strategy to alleviate the burden of obesity and reduce the risk of adiposity-related complications (e.g., NAFLD) by an ER stress- and oxidative stress- relieving nano-platform KT-NE to scavenge excessive ROS and restrain XBP1 hyperactivation in adipose tissues.